These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23145211)

  • 1. Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.
    Kashat M; Azzouz L; Sarkar SH; Kong D; Li Y; Sarkar FH
    Am J Transl Res; 2012; 4(4):432-42. PubMed ID: 23145211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
    Kong D; Heath E; Chen W; Cher M; Powell I; Heilbrun L; Li Y; Ali S; Sethi S; Hassan O; Hwang C; Gupta N; Chitale D; Sakr W; Menon M; Sarkar F
    Am J Transl Res; 2013; 6(1):102-103. PubMed ID: 24349627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
    Kong D; Heath E; Chen W; Cher M; Powell I; Heilbrun L; Li Y; Ali S; Sethi S; Hassan O; Hwang C; Gupta N; Chitale D; Sakr WA; Menon M; Sarkar FH
    Am J Transl Res; 2012; 4(1):14-23. PubMed ID: 22347519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development.
    Li WJ; Liu X; Dougherty EM; Tang DG
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line.
    Mokhtari H; Yaghmaei B; Sirati-Sabet M; Jafari N; Mardomi A; Abediankenari S; Mahrooz A
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):612-623. PubMed ID: 33463130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
    Li WJ; Wang Y; Liu X; Wu S; Wang M; Turowski SG; Spernyak JA; Tracz A; Abdelaal AM; Sudarshan K; Puzanov I; Chatta G; Kasinski AL; Tang DG
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
    Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
    Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
    Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises.
    Li WJ; Wang Y; Liu X; Wu S; Wang M; Turowski SG; Spernyak JA; Tracz A; Abdelaal AM; Sudarshan K; Puzanov I; Chatta G; Kasinski AL; Tang DG
    bioRxiv; 2024 Jan; ():. PubMed ID: 38045265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
    Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
    Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
    de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
    PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation.
    Fineberg SK; Datta P; Stein CS; Davidson BL
    PLoS One; 2012; 7(6):e38562. PubMed ID: 22701667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.
    Du R; Sun W; Xia L; Zhao A; Yu Y; Zhao L; Wang H; Huang C; Sun S
    PLoS One; 2012; 7(2):e30771. PubMed ID: 22363487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
    Roy S; Levi E; Majumdar AP; Sarkar FH
    J Hematol Oncol; 2012 Sep; 5():58. PubMed ID: 22992310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
    Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
    Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression.
    Ai J; Li J; Su Q; Ma H; He R; Wei Q; Li H; Gao G
    Gene Ther; 2022 Aug; 29(7-8):418-424. PubMed ID: 34226687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.